EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
In 2011, the amendment to the Falsified Medicines Directive (FMD) introduced new rules to improve the protection of the public from medicines that are often disguised as authentic ones but contain ingredients of lower quality or in the wrong dosage. The measures contained in Directive 2011/62/EU ensure the use of obligatory safety features – a unique identifier and an anti-tampering device – on the outer packaging of medicines, the application of a common, EU-wide logo to identify legal online pharmacies, the introduction of tougher rules on import of active pharmaceutical ingredients and the strengthening of record-keeping requirements for wholesale distributors.
Detailed rules on the obligatory safety features are regulated by the Commission Delegated Regulation (EU) 2016/161 which lays down the characteristics of these features as well as how medicine authenticity should be verified and by whom. This Delegated Regulation will enter into force on 9th February 2019.
To assist with the implementation of the requirements set out in the FMD and the Delegated Regulation, the European Medicines Verification Organisation (EMVO) was established. EMVO is tasked with the creation of the European Medicines Verification System (EMVS), a repository system that will be connected to and allow for the exchange of data between the 32 national repositories.
EMVO was founded by the European Federation of Pharmaceutical Industries and Associations (EFPIA), Medicines for Europe, the European Association of Euro-Pharmaceutical Companies (EAEPC), the European Healthcare Distribution Association (GIRP) and the Pharmaceutical Group of the European Union (PGEU). In 2017, the European Hospital and Healthcare Federation (HOPE) and EAHP joined the association as affiliate members.
EAHP is closely cooperating with the other stakeholders of EMVO to advance the implementation of the FMD and its Delegated Regulation. In particular a hospital platform has been set up together with EMVO and HOPE to increase awareness and to make the hospital sector ready for the implementation by 9th February 2019.
The 30 member associations of EAHP affected by the FMD and its Delegated Regulation are working towards ensuring that all hospital pharmacists in the EU-28, the European Economic Area and Switzerland are adhering to their scanning and verification obligations. Through raising awareness at national congresses, workshops and mailing campaigns hospital pharmacists are being informed by their national member associations of their obligations. In addition, EAHP’s national member associations have established contact with their national competent authorities to determine how the requirements of the Delegated Regulation can best be implemented in the hospital environment. Funding remains one of the key concerns of hospital pharmacists.
To facilitate the implementation of FMD in the hospital sector, the Member State Expert Group on safety features drafted a paper in September 2018 on the implementation of the safety features in the hospital pharmacy setting. This paper acknowledges the difficulties faced by persons entitled to supply medicines to the public in a hospital setting and proposes the use of aggregation that allows decommissioning multiple unique identifiers from a specific shipment under certain circumstances. In addition, to the Member State Expert Group, also other actors have explored the use of aggregation in the pharmaceutical supply chain. A discussion paper by GS1 has been released and could potentially provide guidance on the implementation of aggregation using GS1 standards, with the goal of underpinning interoperability between distinct implementations, in turn reducing their complexity and cost.
European Commission website on falsified medicines HERE
Delegated Regulation – EAHP public consultation response HERE
Data Matrix and Scanner Tester tool developed for end users by the French NMVO available HERE
